AR and renal pelvis/ureter urothelial carcinoma: In an analysis of 99 cases of UTUC, androgen receptor (AR) was present in approximately 20% of tumours, and AR expression was higher in ureteral cancers than in renal pelvis cancers and tended to be more present in men than in women [17].